Related Experiment Video
Updated: Feb 16, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer
Ayşegül Doğan1,2, Selami Demirci3,4, Dilek Telci3
1Genetics and Bioengineering Department, Faculty of Engineering, Yeditepe University, Kayisdagi, Istanbul, Turkey. aguldgn@gmail.com.
Purpose:
Renal cell carcinoma (RCC) accounts for approximately 80% of the primary renal cancers, and current treatment strategies are not sufficient to provide a certain solution. Since there are not many treatment options, interest in discovery of alternative drugs has increased.
Methods:
In the current study, anticancer activity of a novel heterodinuclear Cu(II)-Mn(II) complex (Schiff base-SB) in combination with poly(ethylene oxide) and poly(propylene oxide) block copolymer (pluronic) P85 was tested against RCC. Cell viability, apoptosis and gene expression analysis were conducted in vitro by using Renca cells.
Results:
The results revealed that the SB-P85 combination decreased cell proliferation by increasing the apoptotic gene expressions and apoptosis. Renca-injected BALB/c mice were used to mimic early stage of RCC model. Treatment with SB-P85 combination suppressed tumor formation and growth compared to baseline.
Conclusion:
Overall, SB-P85 showed promising anticancer activity against RCC in vitro and in vivo.
Insights
A novel copper-manganese complex (SB) combined with pluronic P85 demonstrates significant anticancer effects against renal cell carcinoma (RCC). This SB-P85 combination effectively reduced tumor growth and increased cancer cell death in preclinical models.
Area of Science:
- Oncology
- Materials Science
- Pharmacology
Background:
- Renal cell carcinoma (RCC) is the predominant form of kidney cancer, with limited effective therapeutic options.
- The need for novel and alternative treatment strategies for RCC is critical due to insufficient current therapies.
Purpose of the Study:
- To investigate the anticancer activity of a novel heterodinuclear Cu(II)-Mn(II) complex (Schiff base-SB) in combination with pluronic P85 against RCC.
- To evaluate the efficacy of the SB-P85 combination in preclinical models of renal cell carcinoma.
Main Methods:
- In vitro assessment of SB-P85 combination on Renca cells, including cell viability, apoptosis, and gene expression analysis.
- In vivo evaluation using a Renca-injected BALB/c mouse model to mimic early-stage RCC.
Main Results:
- The SB-P85 combination significantly decreased Renca cell proliferation by enhancing apoptotic gene expression and inducing apoptosis.
- In vivo studies showed that SB-P85 treatment suppressed tumor formation and growth in a murine model of RCC.
Conclusions:
- The SB-P85 combination exhibits promising anticancer activity against renal cell carcinoma.
- This novel complex holds potential as a therapeutic agent for RCC treatment.
Related Concept Videos
Kidney Structure
Acid–Base Equilibria: Activity-Based Definition of pH
In solutions of very low ionic strength—for example, pure water—the...
Kidney Transplant I: Introduction
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Internal Anatomy of the Kidney
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...
Combining Functions

